
Sharing Insights Into a Multiple Myeloma Journey
CURE contributor Ronald D. Chin received a diagnosis of multiple myeloma in 2017 and has been in remission since 2023.
Multiple myeloma survivor Ronald D. Chin, one of CURE’s contributing bloggers, shared a bit of his blood cancer journey in a recent vlog entry for CURE.
Chin received a diagnosis of multiple myeloma in January 2017, and he has been in remission since October 2023.
As a result of his blood cancer, Chin has experienced five fractures in his lower spine and he has lost six inches of height, going from being five feet and eight inches tall to five feet and two inches.
“But,” he states in his vlog, “I am happy to report eight years later now, I am [once again] able to walk, go up and down stairs, go to physical therapy once or twice a week.”
Chen also spotlighted his work with the Multiple Myeloma Research Foundation and his participation in their fundraiser walk as part of a group known as The Bloodhounds.
“And the Bloodhounds are the dogs who are persistent, to find a cure,” Chin shared.
Transcript:
Hi, my name is Ron Chin. I was diagnosed with multiple myeloma back in January of 2017. Unfortunately, five fractures are now in my lower spine. I shrank from [a height of] five [feet] eight [inches] to five [feet] two [inches], but I am happy to report eight years later now, I am able to walk, go up and down stairs, go to physical therapy once or twice a week.
And the screenshot that's behind me is the Spirit of Hope tent, which is part of the Multiple Myeloma Research Foundation fundraiser walk and the woman who created this group called the Bloodhounds. And the Bloodhounds are the dogs who are persistent, to find a cure. So please, read my blogs on curetoday.com, and I hope that my stories will inspire you on your journey through your cancer.
Transcript has been edited for clarity and conciseness.
This piece reflects the author’s personal experience and perspective. For medical advice, please consult your health care provider.
For more news on cancer updates, research and education,





